Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis

Name: Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
Price: 44.92 USD
Availability: InStock
ISBN: 9788847001954

ISBN-10: 8847001951

ISBN-13: 9788847001954

Edition: 2004

Authors: G. Comi, O. R. Hommes

List price: $109.99

30 day, 100% satisfaction guarantee!

Marketplace

3 new & used from $44.92

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

This book reviews the main neurobiological, neurophysiological, MRI and clinical features of the early phases of MS. Mechanisms of irreversible axonal damage and the role played by the interaction between glial and axons are highlighted. Contrary to what was thought for a long time the sufficient availability of oligodendrocyte precursor cells to promote remyelination in acute lesions has now been demonstrated. For not understood reasons, remyelination process fails or does not start in many cases, particularly, in the chronic process of the disease. These findings express the importance of the milieu changes induced by inflammatory process in limiting remyelination. Pathological studies…

Book details

List price: $109.99
Copyright year: 2004
Publisher: Springer Milan
Publication date: 2/6/2004
Binding: Hardcover
Pages: 199
Size: 6.10" wide x 9.25" long x 0.75" tall
Weight: 2.376
Language: English




Evidence for an Early Treatment of Multiple Sclerosis




Inflammation, Demyelination, and Axonal Degeneration: Three Aspects of the Pathogenesis of Multiple Sclerosis Revealed by Campath-1H Treatment




Genetic Regulation of Nerve Cell Death/Glial Activation and Protective Effects of Myelin Basic Protein Autoimmune Neurotrophin Production in Mechanically Induced Neurodegeneration




Neuroprotective Treatment in Primary Progressive Multiple Sclerosis: A Phase I/II Study with Riluzole




Neuropathology and Disease Progression in Multiple Sclerosis




Autoimmune Inflammation and Multiple Sclerosis




Early Treatment of Progression in Multiple Sclerosis




Imaging for Tissue Characterization in Multiple Sclerosis and Other White Matter Diseases




Monounsaturated Fatty Acids and Neuroprotection. The Results of a Study of Cognitive Decline in Old Age. Is There a Case for this Treatment in Multiple Sclerosis?




Neuroprotection in Acute Ischemic Stroke: Lessons for Early Treatment in Multiple Sclerosis




Soluble VCAM-1 Release Indicates Inflammatory Blood-Brain Barrier Pathology and Further Modulates Adhesion




Early Treatment in Multiple Sclerosis with Intravenous Immunoglobulin: Rationale and Study Design




Serial Magnetic Resonance Imaging in Patients with a First Clinical Episode Suggestive of Multiple Sclerosis: Outline of a Research Protocol




T1-Hypointense Lesions (T1 Black Holes) in Mild-to-Moderate Disability Relapsing Multiple Sclerosis




Acute Monosymptomatic Optic Neuritis: Potential Clues to Early Therapy in Multiple Sclerosis




Antibody Mediated Demyelination




Anti-MOG Antibodies as Early Predictors for Conversion to Relapsing-Remitting Disease Course in Patients Suggestive of Multiple Sclerosis




Sunlight, Vitamin D, and Multiple Sclerosis




The Yin and Yang of Inflammation in Multiple Sclerosis




Management of Interferon-[beta]1b (Betaseron) Failures in Multiple Sclerosis with Interferon-[alpha]n3 (Alferon N)



Subject Index